An open clinical trial of clonazepam in the treatment of patients with recurrent panic attacks

Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):589-92. doi: 10.1016/0278-5846(85)90022-3.

Abstract

Imipramine, phenelzine and alprazolam have each been shown to be efficacious in the treatment of panic disorder and in agoraphobia with panic attacks. Clonazepam, a 1,4 benzodiazepine derivative used mainly in neurology as an anti-epileptic, has specific pharmacodynamic and pharmacokinetic properties which would make it an advantageous antipanic agent. We report 8 cases of recurrent panic attacks which were successfully treated with clonazepam.

Publication types

  • Case Reports
  • Clinical Trial

MeSH terms

  • Adult
  • Anxiety / drug therapy*
  • Anxiety / psychology
  • Benzodiazepinones / therapeutic use*
  • Clinical Trials as Topic
  • Clonazepam / therapeutic use*
  • Fear / drug effects*
  • Female
  • Humans
  • Male
  • Panic / drug effects*
  • Recurrence

Substances

  • Benzodiazepinones
  • Clonazepam